PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29551130-6	2018	The first TK to be targeted, Bcr-Abl, led to the generation of several drugs including imatinib, dasatinib, and sunitinib that provided a rich understanding of this phenomenon.	Sunitinib	112-121	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	29-36	
25130811-8	2014	The mRNA expression of C-MYC, hTERT and BCR-ABL was reduced significantly by SU11248 in a time-dependent manner (P < 0.05).	Sunitinib	77-84	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	40-47	
25130811-10	2014	It is concluded that SU11248 can inhibit the growth of K562 cells efficiently through inducing apoptosis, its mechanism may be closely relate with the expression down-regulation of C-MYC, hTERT, BCR-ABL and the inhibition of Akt phosphorylation.	Sunitinib	21-28	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	195-202